Publications

Aster Insights and ORIEN® have published hundreds of papers in dozens of scientific journals.

18+

Years of Data & Insights

115+

Publications

400,000

TCC® Patients

19

ORIEN® Members

Filters

Research Focus

Cancer Type

Data Utilized

ORDER BY

All Publications

    Differences in Co-Expression of T Cell Co-Inhibitory and Co-Stimulatory Molecules with PD-1 Across Different Human Cancers. Tarhini A., Hedges D., Tan A.C., et al

    2024

    Clinical and Genomic Features of Patients with Renal Cell Carcinoma and Advanced Chronic Kidney Disease: Analysis of a Multi-Institutional Database. Eule, C., Hu J., Hedges D., et al

    2024

    CHEK2 founder variants and thyroid cancer risk. Brock P., Liynarachchi S., et al.

    2024

    Profiling the molecular and clinical landscape of glioblastoma utilizing the ORIEN brain cancer database. Demetriou A., Chow F., et al.

    2024

    Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages. Mandula J., Sierra-Mondragon R., et al.

    2024

    Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional Study. Hutchcraft, M., Zhang, S., et al.

    2024

    Genomic Classification and Individualized Prognosis in Multiple Myeloma. Maura, F., Rajanna, A.R., et al.

    2024

    Comparing the rate of immunotherapy treatment change due to toxicity by sex. Chua, K., Kronstedt S, et al.

    2024

    A bioinformatics tool for identifying intratumoral microbes from the ORIEN dataset. Wang C., Ma, A., et al.

    2024

    The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors. Eljilany, I.; Saghand, P.G., et al.

    2023

    Chart A Samples line graph, Chart B table data, Chart C Samples bar graph CRC white paperConsensus Molecular Subtype Analyses in Colorectal Cancer Samples

    April 2023
    Authors: David M. McKean, PhD, Daniel Elgort, PhD, Oliver A. Hampton, PhD, MS, Phaedra Agius, PhD

    Read Whitepaper

    Figure 2 3 charts within RCC White Paper chart OS by Risk Group, StagesIndependent confirmation of the prognostic significance of an immune-related signature in clear cell renal cell carcinoma utilizing real world clinicogenomic data

    April 2023
    Authors: Michael Radmacher, PhD, Daniel Elgort, PhD, Oliver A. Hampton, PhD, MS, and Phaedra Agius, PhD

    Read Whitepaper